83 related articles for article (PubMed ID: 26679360)
21. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
22. Tobacco usage in relation to the anatomical site of oral leukoplakia.
Schepman KP; Bezemer PD; van der Meij EH; Smeele LE; van der Waal I
Oral Dis; 2001 Jan; 7(1):25-7. PubMed ID: 11354917
[TBL] [Abstract][Full Text] [Related]
23. Heat shock proteins (HSP70 and HSP27) as markers of epithelial dysplasia in oral leukoplakia.
Seoane JM; Varela-Centelles PI; Ramirez JR; Cameselle-Teijeiro J; Romero MA; Aguirre JM
Am J Dermatopathol; 2006 Oct; 28(5):417-22. PubMed ID: 17012917
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic significance of cyclin D1, p27 and p63 expression in oral leukoplakia].
Kövesi G; Szende B
Magy Onkol; 2004; 48(4):309-13. PubMed ID: 15655576
[TBL] [Abstract][Full Text] [Related]
25. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemical analysis of cell cycle-associated proteins p27 in oral cancer and precancer].
Hou B; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Feb; 41(2):102-5. PubMed ID: 16640935
[TBL] [Abstract][Full Text] [Related]
27. Effective management of smoking in an oral dysplasia clinic in London.
Poate TW; Warnakulasuriya S
Oral Dis; 2006 Jan; 12(1):22-6. PubMed ID: 16390464
[TBL] [Abstract][Full Text] [Related]
28. Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers.
Mountzios G; Planchard D; Besse B; Validire P; Girard P; Devisme C; Dimopoulos MA; Soria JC; Fouret P
Clin Cancer Res; 2008 Jul; 14(13):4096-102. PubMed ID: 18593986
[TBL] [Abstract][Full Text] [Related]
29. Expression of p27 and Jun activation domain-binding protein 1 in endometriosis.
Kim TH; Lee HH; Chung SH; Park J; Lee A
Arch Gynecol Obstet; 2015 Aug; 292(2):377-81. PubMed ID: 25666480
[TBL] [Abstract][Full Text] [Related]
30. Pre-malignant lesions of the oral mucosa in a South African sample--a clinicopathological study.
Feller L; Altini M; Slabbert H
J Dent Assoc S Afr; 1991 May; 46(5):261-5. PubMed ID: 1962315
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280).
Majumder M; Sikdar N; Paul RR; Roy B
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2106-12. PubMed ID: 16172217
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of cell proliferation rate in non-dysplastic leukoplakias.
Hildebrand LD; Carrard VC; Lauxen ID; de Quadros OF; Chaves AC; Sant' Ana-Filho M
Med Oral Patol Oral Cir Bucal; 2010 Mar; 15(2):e328-34. PubMed ID: 19767704
[TBL] [Abstract][Full Text] [Related]
33. Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern Chinese.
Huang B; Liu B; Yang L; Li Y; Cheng M; Huang D; Wang H; Zhang X; Zheng J; Li Q; Ji W; Zhou Y; Lu J
Int J Cancer; 2012 Sep; 131(5):E744-58. PubMed ID: 22189957
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of DARPP-32 in oral premalignant and malignant lesions.
Pimenta FJ; Horta MC; Vidigal PV; De Souza BR; De Marco L; Romano-Silva MA; Gomez RS
Anticancer Res; 2007; 27(4B):2339-43. PubMed ID: 17695523
[TBL] [Abstract][Full Text] [Related]
35. [Oral leukoplakia. A retrospective study of clinical and histological data].
Bornstein MM; Benguerel MC; Magnin P; Meier E; Buser D
Schweiz Monatsschr Zahnmed; 2004; 114(7):680-6. PubMed ID: 15360103
[TBL] [Abstract][Full Text] [Related]
36. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
37. Is salivary epidermal growth factor a biomarker for oral leukoplakia? A preliminary study.
Jaeger F; Assunção AC; Caldeira PC; Queiroz-Junior CM; Bernardes VF; de Aguiar MC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Apr; 119(4):451-8. PubMed ID: 25701553
[TBL] [Abstract][Full Text] [Related]
38. The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions.
Vladimirov BS; Schiodt M
Int J Oral Maxillofac Surg; 2009 Nov; 38(11):1188-93. PubMed ID: 19640683
[TBL] [Abstract][Full Text] [Related]
39. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
40. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
